Intrapartum antibiotics for known maternal Group B streptococcal colonisation

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Ohlsson, Arne ^a   Shah, Vibhuti S ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

BACTERIAL COLONIZATION; CHILD DEVELOPMENT; CHORIOAMNIONITIS; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; HOSPITALIZATION; HUMAN; INTESTINE INFECTION; INTRAPARTUM CARE; MORTALITY; NEWBORN MORBIDITY; REVIEW; SEPSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; VAGINITIS;

EID: 55049091858     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007467     Document Type: Review

References (71)

1. AAP 1992 American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal infection by chemoprophylaxis. Pediatrics 1992;90:775-8.
2. AAP 1997 American Academy of Pediatrics, Committee on Infectious Diseases/Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) disease. Pediatrics 1997;99:489-96.
3. Ablow 1976 Ablow RC, Driscoll SG, Effman EL, Gross I, Jolles CJ, Uauy R, et al.A comparison of early-onset group B streptococcal neonatal infection and the respiratory distress syndrome of the newborn. New England Journal of Medicine 1976;294:65-70.
4. ACOG 1992 Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Group B streptococcal infections in pregnancy. ACOG Technical Bulletin no. 170. ACOG, July 1992.
5. ACOG 1996 American College of Obstetricians and Gynecologists, Committee on Obstetric Practice. Prevention of early-onset group B streptococcal disease in newborns [Opinion 173]. Washington DC: American College of Obstetricians and Gynecologists, 1996.
6. Allardice 1982 Allardice JG, Baskett TF, Seshia MMK, Bowman N, Malazdrewicz R. Perinatal group B streptococcal colonization and infection. American Journal of Obstetrics and Gynecology 1982;142:617-20.
7. Baker 1973 Baker CJ, Barrett FF. Transmission of group B streptococci among parturient women and their neonates. Journal of Pediatrics 1973;83:919-25.
8. Barcaite 2008 Barcaite E, Bartusevicius A, Tameliene R, Kliucinskas M, Maleckiene L, Nadisauskiene R. Prevalence of maternal group B streptococcal colonisation in European countries. Acta Obstetrica and Gynecologica Scandinavica 2008;87:260-71.
9. Bergqvist 1974 Bergqvist G. Neonatal infections caused by group B streptococci. Scandinavian Journal of Infectious Diseases 1974;6:29-31.
10. Berthier 2007 Berthier A, Senthiles L, Hamou L, Renoult-Litzler D, Marret S, Marpeau L. Antibiotics at term. Questions about five allergic accidents. Gynécologie, Obstétrique & Fertilité 2007;35:464-72.
11. Carbonell-Estrany 2008 Carbonell-Estrany X, Figueras-Aloy J, Salcedo-Abizanda S, de la Rosa-Fraile M, Castrillo Study Group. Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection. Archives of Disease in Childhood. Fetal Neonatal Edition 2008;93(2):F85-F89.
12. Cayeux 1972 Cayeux P. Neonatal infections with B group streptococci. Etiological verification. Apropos of 77 cases [Infections néonatales à streptocoques du groupe B. Constatations etiologiques. A propos de 77 observations]. Archives Françaises de Pédiatrie 1972;29(4):391-6.
13. CDC 1996 Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: a public health perspective. Morbidity and Mortality Weekly Report 1996;45 (RR-7):1-24.
14. CDC 2002 Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease. Morbidity and Mortality Weekly Reports 2002;51 (RR11):1-22.
15. CDC 2005 Centers for Disease Control and Prevention (CDC). Early-onset and late-onset neonatal group B streptococcal disease - United States, 1996-2004. Morbidity and Mortality Weekly Report 2005;54(47):1205-8.
16. CDC 2007 Centers for Disease Control and Prevention (CDC). Perinatal group B streptococcal disease after universal screening recommendations - United States, 2003-2005. Morbidity and Mortality Weekly Report 2007;56:701-5.
17. Christensen 1983 Christensen KK, Christensen P, Dahlander K, Linden V, Lindroth M, Svenningsen N. The significance of group B streptococci in neonatal pneumonia. European Journal of Pediatrics 1983;140:118- 22.
18. Deeks 2001 Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results fromseveral studies in meta-analysis. Egger M, Davey Smith G, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. London: BMJ Books, 2001.
19. Dillon 1987 Dillon HC, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6-year prospective study. Journal of Pediatrics 1987;110:31-6.
20. Dinsmoor 2005 Dinsmoor MJ, Viloria R, Leif L, Elder S. Use of intrapartum antibiotics and the incidence of postnatal maternal and neonatal yeast infections. Obstetetrics & Gynecology 2005;106:19-22.
21. Edwards 2002 Edwards RK, Clark P, Sistrom CL, Duff P. Intrapartum antibiotic prophylaxis 1: Relative effects of recommended antibiotics on gram-negative pathogens. Obstetrics & Gynecology 2002;100:534- 9.
22. Eickhoff 1964 Eickhoff TC, Klein JO, Daly AK, Ingall D, Finland M. Neonatal sepsis and other infections due to group B beta-hemolytic streptococci. New England Journal of Medicine 1964;271:1221-8.
23. Fliegner 1990 Fliegner JR, Garland SM. Perinatal mortality in Victoria, Australia; role of group B streptococcus. American Journal of Obstetrics and Gynecology 1990;163:1609-11.
24. Garland 1991 Garland SM. Early onset neonatal group B streptococcus (GBS) infection: associated obstetric risk factors. Australian and New Zealand Journal of Obstetrics and Gynaecology 1991;10:801-8.
25. Gates 2005 Gates S. Methodological Guidelines. In: The Editorial Team. Pregnancy and Childbirth Group. About the Cochrane Collaboration (Collaborative Review Groups (CRGs)) 2005, Issue 2.
26. Gavino 2007 Gavino M, Wang E. A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization. American Journal of Obstetrics and Gynecology 2007;197:388.e1-e4.
27. Goldenberg 2006 Goldenberg RL, McClure EM, Saleem S, Rouse D, Vermund S. Use of vaginally administered chlorhexidine during labor to improve pregnancy outcomes. Obstetetrics & Gynecology 2006;107:1139- 46.
28. Group B Strep Association 2008 Group B Strep Association. Historical background. http://www.groupbstrep.org (accessed 2008).
29. Hamada 2008 Hamada S, Vearncombe M, McGeer A, Shah PS. Neonatal group B streptococcal disease: incidence, presentation, and mortality. Journal of Maternal-Fetal and Neonatal Medicine 2008;21:53-7.
30. Hannah 1997 Hannah ME, Ohlsson A, Wang EEL, Matlow A, Foster GA, Willan AR, et al.Maternal colonization with group B streptococcus and prelabor rupture of the membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology 1997;177:780-5.
31. Hastings 1986 Hastings MJG, Easmon CSF, Neill J, Bloxham B, Rivers RPA. Group B streptococcal colonisation and the outcome of pregnancy. Journal of Infection 1986;12:23-9.
32. Higgins 2008 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochranehandbook. org.
33. Ho 2006 Ho CM, Chi CY, Ho MW, Chen CM, Liao WC, Liu YM, et al. Clinical characteristics of group B streptococcus bacteremia in nonpregnant adults. Journal of Microbiology, Immunology and Infection 2006;39:396-401.
34. Honest 2006 Honest H, Sharma S, Khan KS. Rapid tests for group B streptococcus colonization in laboring women: a systematic review. Pediatrics 2006;117:1055-66.
35. Håkansson 2006 Håkansson S, Källén K. Impact and risk factors for early-onset group B streptococcal morbidity: analysis of a national, population-based cohort in Sweden 1997-2001. BJOG: an international journal of obstetrics and gynaecology 2006;113:1452-8.
36. Institue of Medicine 1985 Institute of Medicine. Prospects for immunizing against Streptococcus Group B. New vaccine development. Establishing priorities. Diseases of importance in the United States. Vol. 1, Washington, DC: National Academy Press, 1985.
37. Jao 2006 Jao MS, Cheng PJ, Shaw SW, Soong YK. Anaphylaxis to cefazolin during labor secondary to prophylaxis for group B Streptococcus: a case report. The Journal of Reproductive Medicine 2006;51:655-8.
38. Johri 2006 Johri AK, Paoletti LC, Glaser P, Dua M, Sharma PK, Grandi G, et al.Group B Streptococcus: global incidence and vaccine development. Nature Reviews. Microbiology 2006;4:932-42.
39. Lancefield 1933 Lancefield R. A serological differentiation of human and other groups of haemolytic streptococci. Journal of Experimental Medicine 1933;57:571-95.
40. Lancefield 1935 Lancefield R, Hare R. The serological differentiation of pathogenic and non-pathogenic strains of haemolytic streptococci from parturient women. Journal of Experimental Medicine 1935;61:335-49.
41. Lloyd 1976 Lloyd DJ, Reid TM. Group B streptococcal infection in the newborn. Criteria for early detection and treatment. Acta Paediatrica Scandinavica 1976;65(5):585-91.
42. McCracken 1973 McCracken GH. Group B streptococci: the new challenge in neonatal infections. Journal of Pediatrics 1973;82:703-6.
43. McNanley 2007 McNanley AR, Glantz C, Hardy DJ, Vicino D. The effect of intrapartum penicillin on vaginal group B streptococcus colony counts. American Journal of Obstetrics and Gynecology 2007;197:583.e1-e4.
44. Mereghetti 2007 Mereghetti L, Lanotte P, Rochoux A, Sauget AS, Chevillot M, Perrotin F, et al.Application of the French guidelines for preventing neonatal group B streptococcal disease in a university hospital. Clinical Microbiology and Infection 2007;13:322-4.
45. Nyhan 1958 Nyhan WL, Fousek MD. Septicemia of the newborn. Pediatrics 1958;22:268-78.
46. Ohlsson 1986 Ohlsson A, Bailey T, Takieddine F. Changing etiology and outcome of neonatal septicemia in Riyadh, Saudi Arabia. Acta Paediatrica Scandinavica 1986;75:540-44.
47. Ohlsson 1992 Ohlsson A. Perinatal group B streptococcal infections. Canadian Journal of Obstetrics/Gynaecology & Women's Health Care 1992;4:355-63.
48. Ohlsson 1994 Ohlsson A, Myhr TL. Intrapartum chemoprophylaxis of perinatal group B streptococcal infections: a critical review of randomized controlled trials. American Journal of Obstetrics and Gynecology 1994;170:910-7.
49. Ohlsson 1999 Ohlsson A, Walia R. Differences between information provided in abstracts of randomized controlled trials in neonates submitted to the Annual Meeting of the American Pediatric Society and the Society for Pediatric Research (APS/SPR) and final publications? Implications for meta-analyses. VII Cochrane Colloquium. The Best Evidence for Health Care: The Role of the Cochrane Collaboration; 1999 October 6-9; Rome, Italy. 1999.
50. Osrin 2004 Osrin D, Vergnano S, Costello A. Serious bacterial infections in newborn infants in developing countries. Currrent Opinion in Infectious Diseases 2004;17:217-24.
51. RCOG 2003 Royal College of Obstetricians and Gynaecologists. Prevention of early onset neonatal group B streptococcal disease. http://www.rcog.org.uk/resources/Public/pdf/GroupB_strep_no36.pdf (accessed 2008) 2003.
52. RevMan 2008 The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2008.
53. Schrag 2002 Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold K, Craig AS, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. New England Journal of Medicine 2002;347:233-9.
54. Schröder 1979 Schröder H, Paust H. Group B streptococci: the most common cause of neonatal septicemia [B-Streptokokken als haufigste Erreger der Neugeborenensepsis. Einleitung, Haufigkeit, Klinik, Therapie]. Monatsschrift für Kinderheilkunde 1979;127:720-3.
55. Schuchat 1990 Schuchat A, Oxtoby M, Cochi S, Sikes RK, Hightower A, Plikaytis B, et al.Population-based risk factors for neonatal Group B streptococcal disease: results of a cohort study in metropolitan Atlanta. Journal of Infectious Diseases 1990;162:672-7.
56. Shah 2001 Shah V, Ohlsson A, The Canadian Task Force on Preventive Health Care. Prevention of early-onset Group B Streptococcal (GBS) infection in the newborn: systematic review and recommendations. Technical report. The Canadian Task Force on Preventive Health Care (www.ctfphc.org) (accessed 2008) 2001.
57. Sinha 2005 Sinah A, Lieu TA, Paoletti LC, Weinstein MC, Platt R. The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. Vaccine 2005;23:3187-95.
58. Slotved 2007 Slotved H-C, Kong F, Lambertsen L, Sauer S, Gilbert GL. Serotype IX, a proposed new Streptococcus agalactiae serotype. Journal of Clinical Microbiology 2007;45:2929-36.
59. SOGC 1994 Society of Obstetricians and Gynaecologists of Canada, Canadian Paediatric Society. National consensus statement on the prevention of early onset group B streptococcal infections in the newborn. Journal of the Society of Obstetricians and Gynaecologists of Canada 1994;16:2271-8.
60. SOGC 1997 Society of Obstetricians and Gynaecologists. Statement on the prevention of early-onset group B streptococcal infections in the newborn. Journal of the Society of Obstetricians and Gynaecologists of Canada 1997;19:751-8.
61. SOGC 2004 Society of Obstetricians and Gynaecologist of Canada. The prevention of early-onset group B streptococcal infections in newborns. Journal of Obstetrics and Gynaecology of Canada 2004;26:826-32.
62. Stade 2004 Stade B, Shah V, Ohlsson A. Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD003520.pub2]
63. Stoll 1998 Stoll BJ, Schuchat A. Maternal carriage of group B streptococci in developing countries. The Pediatric Infectious Disease Journal 1998;17:499-503.
64. Van den Akker 2005 Van den Akker van Marle ME, Rijnders MEB, van Dommelen P, Fekkes M, van Wouwe JP, Amelink-Verburg MP, et al.Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease. BJOG: an international journal of obstetrics and gynaecology 2005;112:820-6.
65. Vesikari 1989 Vesikari T, Isolauri E, Tuppurainen N, Janas M, Koivisto M, Kero P, et al.Neonatal septicaemia in Finland 1981-85. Predominance of group B streptococcal infections with very early onset. Acta Paediatrica Scandinavica 1989;78:44-50.
66. Wood 1981 Wood EG, Dillon HC. A prospective study of group B streptococcal bacteriuria in pregnancy. American Journal of Obstetrics and Gynecology 1991;140:515-20.
67. Yagupsky 1991 Yagupsky P, Menegus MA, Powell KR. The changing spectrum of group B streptococcal disease in infants: an eleven-year experience in a tertiary care hospital. Pediatric Infectious Disease Journal 1991;10:801-8.
68. Yodin 2006 Yudin MH, Shah V, Ohlsson A, Farine D. Are we using the optimal strategy for GBS management in pregnancy?. Journal of Obstetrics and Gynaecology Canada 2006;28:499-500.
69. Yow 1979 Yow MD, Mason EO, Leeds LJ, Thompson PK, Clark DJ, Gardener SE. Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA 1979;241:1245-7.
70. Smaill 1992 Smaill F. Intrapartum antibiotics for Group B streptococcal colonisation. Oxford database of perinatal trials 1992; Vol. Version 1.3, Disk Issue 7:Record 3006.
71. Smaill 1996 Smaill FM. Intrapartumantibiotics for Group B streptococcal colonisation. Cochrane Database of Systematic Reviews 1996, Issue 1. [DOI: 10.1002/14651858.CD000115]